C07K 14/7155
For interleukins [il]
Official title: {for interleukins [IL]}
C07K14/7155 (For interleukins [il]) appears on 987 US grants and 1,785 published applications in this corpus.
Search patents in C07K- Granted patents
- 987
- Published applications
- 1,785
- Assignees
- 658
- Inventors
- 2,862
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 5 | 0 |
| 1993 | 9 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 13 | 0 |
| 1997 | 13 | 0 |
| 1998 | 32 | 0 |
| 1999 | 29 | 0 |
| 2000 | 17 | 0 |
| 2001 | 20 | 4 |
| 2002 | 12 | 31 |
| 2003 | 23 | 44 |
| 2004 | 12 | 46 |
| 2005 | 17 | 50 |
| 2006 | 24 | 34 |
| 2007 | 27 | 53 |
| 2008 | 26 | 37 |
| 2009 | 25 | 48 |
| 2010 | 28 | 33 |
| 2011 | 27 | 42 |
| 2012 | 20 | 29 |
| 2013 | 20 | 33 |
| 2014 | 16 | 33 |
| 2015 | 19 | 38 |
| 2016 | 19 | 33 |
| 2017 | 22 | 45 |
| 2018 | 25 | 61 |
| 2019 | 33 | 69 |
| 2020 | 56 | 104 |
| 2021 | 58 | 144 |
| 2022 | 62 | 139 |
| 2023 | 69 | 186 |
| 2024 | 69 | 171 |
| 2025 | 86 | 174 |
| 2026 | 38 | 104 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Drug-specific pharmacokinetic assay for IL-15 superagonist6 Oct 2026US 12,754,189 B2NantCell, Inc.
- Effective dosages of an adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis in humans, and compositions comprising the same25 Aug 2026US 12,714,755 B2Pacira Therapeutics, Inc.
- Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist18 Aug 2026US 12,708,666 B2Regeneron Pharmaceuticals, Inc.
- Methods for treating chronic rhinosinusitis with nasal polyps by administering an antibody antagonist of IL-4R11 Aug 2026US 12,702,709 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Chimeric receptors8 Oct 2026US 2026/0306631 A1St. Jude Children?S Research Hospital
- A novel il-15r alpha fc fusion protein and uses thereof8 Oct 2026US 2026/0308234 A1Staidson Biopharma Inc.
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Il12rb2 binding molecules and methods of use8 Oct 2026US 2026/0308265 A1Synthekine, Inc.
- Rapamycin resistant cells8 Oct 2026US 2026/0308637 A1Seattle Children's Hospital (dba Seattle Children's Research Institute)
Most cited
By later US patents
- Antibody to human interleukin-6 receptor203US 5,670,373 A1997
- Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells200US 6,653,104 B2Immunomedics, Inc. · 2003
- Chimeric CTLA4 receptor and methods for its use199US 5,434,131 ABristol-Myers Squibb Company · 1995
- Chimeric receptor genes and cells transformed therewith196US 8,211,422 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2012
- Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell179US 6,132,992 ABristol-Myers Squibb Company · 2000